Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 43 (RPL17P43)

Target: RPL17P43
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L17 pseudogene 43 (RPL17P43) is a processed pseudogene in the human genome, annotated based on sequence similarity to the ribosomal protein L17 gene (RPL17). Unlike the functional RPL17 gene (which codes for a component of the large subunit of cytoplasmic ribosomes, involved in protein synthesis), RPL17P43 does not produce a functional protein. It is one of multiple processed pseudogenes derived from the RPL17 gene, following the widespread phenomenon of ribosomal protein gene duplication and retrotransposition in the genome[1][4][10]. There is currently no evidence for any functional or pathological relevance of RPL17P43 in human biology.

Other names: RPL17_24_1526RPL17P43

Biological functions

Other

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 43 (RPL17P43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 43 (RPL17P43).

Explore the full profile